Authors: STRICKER W WEINSTEIN S CHERVINSKY P WOODRING A PRILLAMAN B SHAH T

Citation: W. Stricker et al., ADDITIVE BENEFITS OF CONCURRENT SALMETEROL AND FLUTICASONE PROPIONATETHERAPY IN ASTHMA, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1306-1306

Authors: NIELSEN K OKAMOTO L BROWN A WOODRING A SHAH T

Citation: K. Nielsen et al., FACTORS OF INHALATION DEVICES RATED IMPORTANT BY PATIENTS WITH ASTHMAAND THE PERFORMANCE OF THE DISKHALER(R), Journal of allergy and clinical immunology, 95(1), 1995, pp. 230-230

Authors: LAWRENCE M ZIERING W WOLFE J CHERVINSKY P WEBB DR WOODRING A HAMEDANI A KELLERMAN D SHAH T

Citation: M. Lawrence et al., EFFICACY OF INHALED FLUTICASONE PROPIONATE (FP) IN ASTHMA OCCURS VIA TOPICAL RATHER THAN SYSTEMIC EFFECT, Journal of allergy and clinical immunology, 95(1), 1995, pp. 311-311